MONTREAL (AP) _ Aeterna Zentaris Inc. (AEZS) on Wednesday reported a loss of $8.2 million in its fourth quarter.
On a per-share basis, the Montreal-based company said it had a loss of 71 cents.
The drug developer posted revenue of $304,000 in the period.
For the year, the company reported that its loss narrowed to $25 million, or $2.41 per share. Revenue was reported as $911,000.
In the final minutes of trading on Wednesday, the company's shares hit $3. A year ago, they were trading at $3.56.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AEZS at https://www.zacks.com/ap/AEZS
Keywords: Aeterna Zentaris, Earnings Report